[Biphosphonates and intraocular inflammation].
PURPOSE/MATERIAL AND METHOD: A 67 year old woman had been taking oral alendronate in a single weekly dose of 70 mg. She developed panuveitis in her right eye and anterior uveitis in the left. The uveitis was resolved with steroids and discontinuation of alendronate. Three weeks later alendronate was reinstituted and this produced a recurrence. Her past medical history revealed that she had a temporal arteritis but her past ocular history was unremarkable.


CONCLUSIONS
Disodium alendronate can cause intraocular inflammation (panuveitis and anterior uveitis), which requires discontinuing the treatment.
Asensio Sánchez
V M
VM
Hospital General, Medina del Campo, Valladolid, Spain.
Botella Oltra
G
G
Carrasco
E
E
D000368:Aged; D019386:Alendronate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015864:Panuveitis / Q000139:chemically induced / Q000503:physiopathology; D012008:Recurrence; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000503:physiopathology; D014792:Visual Acuity
D019386:Alendronate